<?xml version='1.0'?><!DOCTYPE Annotation PUBLIC "//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN_Modified" "../ModifiedGENIAtypes/Modified_GENIA_event_20.dtd"><Annotation annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=10415075" created="03/07/2006" creator="Noriko Katsu"><PubmedArticleSet><PubmedArticle><MedlineCitation>
<PMID>10415075</PMID>
<Article>
<ArticleTitle>
<sentence id="S1">Abnormal <term id="A5" sem="Other"><term id="T1" lex="NF-kappa_B" sem="Protein_complex">NF-kappa B</term> activity</term> in <term id="T2" lex="T_lymphocyte" sem="Cell_natural">T lymphocytes</term> from <term id="T3" lex="patient" sem="Multicellular_organism_natural">patients</term> with <term id="T4" lex="systemic_lupus_erythematosus" sem="Other">systemic lupus erythematosus</term> is associated with decreased <term id="T5" lex="p65-RelA_protein_expression" sem="Other"><term id="T6" lex="p65-RelA" sem="Protein_complex">p65-RelA</term> protein expression</term>.</sentence>
<event KT="Analysis" id="E1">
<type class="Correlation"/>
<theme idref="E2"/>
<theme idref="E3"/>
<clue>Abnormal NF-kappa B activity in T lymphocytes from patients with systemic lupus erythematosus is <clueType><clueKT>associated</clueKT></clueType> <linkTheme>with</linkTheme> decreased p65-RelA protein expression.</clue>
</event>
<event KT="Other" id="E2">
<type class="Negative_regulation"/>
<theme idref="A5"/>
<clue><clueType>Abnormal</clueType> NF-kappa B activity <clueLoc>in T lymphocytes from patients with systemic lupus erythematosus</clueLoc> is associated with decreased p65-RelA protein expression.</clue>
</event>
<event KT="Other" id="E3">
<type class="Negative_regulation"/>
<theme idref="E4"/>
<clue>Abnormal NF-kappa B activity in T lymphocytes from patients with systemic lupus erythematosus is associated with <clueType>decreased</clueType> p65-RelA protein expression.</clue>
</event>
<event KT="Other" id="E4">
<type class="Gene_expression"/>
<theme idref="T6"/>
<clue>Abnormal NF-kappa B activity in T lymphocytes from patients with systemic lupus erythematosus is associated with decreased p65-RelA protein <clueType>expression</clueType>.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2">Numerous cellular and biochemical abnormalities in <term id="T7" lex="immune_regulation" sem="Other">immune regulation</term> have been described in <term id="T8" lex="patient" sem="Multicellular_organism_natural">patients</term> with <term id="T9" lex="systemic_lupus_erythematosus" sem="Other">systemic lupus erythematosus</term> (<term id="T10" lex="SLE" sem="Other">SLE</term>), including <term id="T11" lex="surface_Ag_receptor-initiated_signaling_event" sem="Other">surface <term id="T12" lex="Ag_receptor" sem="Protein_family_or_group">Ag receptor</term>-initiated signaling events</term> and <term id="T13" lex="lymphokine_production" sem="Other"><term id="T14" lex="lymphokine" sem="Protein_family_or_group">lymphokine</term> production</term>.</sentence>
<event KT="Analysis" Source="Other" id="E31">
<type class="Negative_regulation"/>
<theme idref="E5"/>
<clue>Numerous cellular and biochemical <clueType>abnormalities</clueType> <linkTheme>in</linkTheme> <corefTheme>immune regulation</corefTheme> <clueSource>have been</clueSource> <clueKT>described</clueKT> <clueLoc>in patients with systemic lupus erythematosus (SLE)</clueLoc>, including surface Ag receptor-initiated signaling events and lymphokine production.</clue>
</event>
<event KT="Analysis" Source="Other" id="E32">
<type class="Negative_regulation"/>
<theme idref="E6"/>
<clue>Numerous cellular and biochemical <clueType>abnormalities</clueType> <linkTheme>in</linkTheme> <corefTheme>immune regulation</corefTheme> <clueSource>have been</clueSource> <clueKT>described</clueKT> <clueLoc>in patients with systemic lupus erythematosus (SLE)</clueLoc>, including surface Ag receptor-initiated signaling events and lymphokine production.</clue>
</event>
<event KT="Other" id="E5">
<type class="Cell_communication"/>
<theme idref="T12"/>
<clue>Numerous cellular and biochemical abnormalities in immune regulation have been described in patients with systemic lupus erythematosus (SLE), including <clueLoc>surface</clueLoc> Ag receptor<linkTheme>-initiated</linkTheme> <clueType>signaling</clueType> events and lymphokine production.</clue>
</event>
<event KT="Other" id="E6">
<type class="Gene_expression"/>
<theme idref="T14"/>
<clue>Numerous cellular and biochemical abnormalities in immune regulation have been described <clueLoc>in patients with systemic lupus erythematosus (SLE)</clueLoc>, including surface Ag receptor-initiated signaling events and lymphokine <clueType>production</clueType>.</clue>
</event>
<sentence id="S3">Because <term id="T15" lex="NF-kappa_B" sem="Protein_complex">NF-kappa B</term> contributes to the transcription of numerous <term id="T16" lex="inflammatory_gene" sem="DNA_family_or_group">inflammatory genes</term> and has been shown to be a molecular target of <term id="T17" lex="antiinflammatory_drug" sem="Organic_compound_other">antiinflammatory drugs</term>, we sought to characterize the functional role of the <term id="T18" lex="NF-kappa_B_protein_complex" sem="Protein_complex"><term id="T19" lex="NF-kappa_B" sem="Protein_complex">NF-kappa B</term> protein complex</term> in <term id="T20" lex="lupus_T_cell" sem="Cell_natural">lupus T cells</term>.</sentence>
<event KT="Fact" id="E7">
<type class="Positive_regulation"/>
<theme idref="E8"/>
<cause idref="T15"/>
<clue>Because NF-kappa B <clueType>contributes</clueType> <linkTheme>to</linkTheme> the transcription of numerous inflammatory genes and has been shown to be a molecular target of antiinflammatory drugs, we sought to characterize the functional role of the NF-kappa B protein complex in lupus T cells.</clue>
</event>
<event KT="Other" id="E8">
<type class="Transcription"/>
<theme idref="T16"/>
<clue>Because NF-kappa B contributes to the <clueType>transcription</clueType> <linkTheme>of</linkTheme> numerous inflammatory genes and has been shown to be a molecular target of antiinflammatory drugs, we sought to characterize the functional role of the NF-kappa B protein complex in lupus T cells.</clue>
</event>
<event KT="Analysis" Source="Other" id="E9">
<type class="Regulation"/>
<theme idref="T15"/>
<cause idref="T17"/>
<clue>Because NF-kappa B contributes to the transcription of numerous inflammatory genes and <clueSource>has been</clueSource> <clueKT>shown</clueKT> to be a molecular <clueType>target</clueType> <linkCause>of</linkCause> antiinflammatory drugs, we sought to characterize the functional role of the NF-kappa B protein complex in lupus T cells.</clue>
</event>
<event KT="Investigation" id="E10" uncertainty="doubtful">
<type class="Regulation"/>
<cause idref="T19"/>
<clue>Because NF-kappa B contributes to the transcription of numerous inflammatory genes and has been shown to be a molecular target of antiinflammatory drugs, we sought <clueKT>to characterize</clueKT> the functional <clueType>role</clueType> <linkCause>of</linkCause> the NF-kappa B protein complex <clueLoc>in lupus T cells</clueLoc>.</clue>
<comment>NO THEME</comment></event>
<sentence id="S4">Freshly isolated <term id="T21" lex="T_cell" sem="Cell_natural">T cells</term> from <term id="T22" lex="lupus_patient" sem="Multicellular_organism_natural">lupus <term id="T23" lex="patient" sem="Multicellular_organism_natural">patients</term></term>, <term id="T24" lex="rheumatoid_arthritis" sem="Other">rheumatoid arthritis</term> (<term id="T25" lex="RA" sem="Other">RA</term>) <term id="T26" lex="patient" sem="Multicellular_organism_natural">patients</term>, and <term id="T27" lex="normal_individual" sem="Multicellular_organism_natural">normal individuals</term> were activated physiologically via the <term id="T28" lex="TCR" sem="Protein_family_or_group">TCR</term> with <term id="T29" lex="anti-CD3" sem="Protein_family_or_group">anti-CD3</term> and <term id="T30" lex="anti-CD28_Ab" sem="Protein_family_or_group">anti-CD28 <term id="A1" sem="Protein_family_or_group">Abs</term></term> to assess proximal membrane signaling, and with <term id="T31" lex="PMA" sem="Organic_compound_other">PMA</term> and a <term id="T32" lex="calcium_ionophore" sem="Organic_compound_other">calcium ionophore</term> (<term id="T33" lex="A23187" sem="Organic_compound_other">A23187</term>) to bypass <term id="T34" lex="membrane-mediated_signaling_event" sem="Other">membrane-mediated signaling events</term>.</sentence>
<event id="E11">
<type class="Physiological_process"/>
<theme idref="T21"/>
<cause idref="E13"/>
<clue>Freshly isolated T cells from lupus patients, rheumatoid arthritis (RA) patients, and normal individuals were <clueType>activated</clueType> physiologically <linkCause>via</linkCause> the TCR with anti-CD3 and anti-CD28 Abs to assess proximal membrane signaling, and with PMA and a calcium ionophore (A23187) to bypass membrane-mediated signaling events.</clue>
</event>
<event id="E12">
<type class="Physiological_process"/>
<theme idref="T21"/>
<cause idref="E14"/>
<clue>Freshly isolated T cells from lupus patients, rheumatoid arthritis (RA) patients, and normal individuals were <clueType>activated</clueType> physiologically <linkCause>via</linkCause> the TCR with anti-CD3 and anti-CD28 Abs to assess proximal membrane signaling, and with PMA and a calcium ionophore (A23187) to bypass membrane-mediated signaling events.</clue>
</event>
<event id="E13">
<type class="Binding"/>
<theme idref="T28"/>
<theme idref="T29" idref1="A1"/>
<clue>Freshly isolated T cells from lupus patients, rheumatoid arthritis (RA) patients, and normal individuals were activated physiologically via the TCR <linkTheme>with</linkTheme> anti-CD3 and anti-CD28 Abs to assess proximal membrane signaling, and with PMA and a calcium ionophore (A23187) to bypass membrane-mediated signaling events.</clue>
<comment>NO CLUETYPE</comment></event>
<event id="E14">
<type class="Binding"/>
<theme idref="T28"/>
<theme idref="T30"/>
<clue>Freshly isolated T cells from lupus patients, rheumatoid arthritis (RA) patients, and normal individuals were activated physiologically via the TCR <linkTheme>with</linkTheme> anti-CD3 and anti-CD28 Abs to assess proximal membrane signaling, and with PMA and a calcium ionophore (A23187) to bypass membrane-mediated signaling events.</clue>
<comment>NO CLUETYPE</comment></event>
<event id="E15">
<type class="Physiological_process"/>
<theme idref="T21"/>
<cause idref="E17"/>
<clue>Freshly isolated T cells from lupus patients, rheumatoid arthritis (RA) patients, and normal individuals were <clueType>activated</clueType> physiologically <linkCause>via</linkCause> the TCR with anti-CD3 and anti-CD28 Abs to assess proximal membrane signaling, and with PMA and a calcium ionophore (A23187) to bypass membrane-mediated signaling events.</clue>
</event>
<event id="E16">
<type class="Physiological_process"/>
<theme idref="T21"/>
<cause idref="E18"/>
<clue>Freshly isolated T cells from lupus patients, rheumatoid arthritis (RA) patients, and normal individuals were <clueType>activated</clueType> physiologically <linkCause>via</linkCause> the TCR with anti-CD3 and anti-CD28 Abs to assess proximal membrane signaling, and with PMA and a calcium ionophore (A23187) to bypass membrane-mediated signaling events.</clue>
</event>
<event id="E17">
<type class="Binding"/>
<theme idref="T29"/>
<theme idref="T31"/>
<clue>Freshly isolated T cells from lupus patients, rheumatoid arthritis (RA) patients, and normal individuals were activated physiologically via the TCR with anti-CD3 and anti-CD28 Abs to assess proximal membrane signaling, and <linkTheme>with</linkTheme> PMA and a calcium ionophore (A23187) to bypass membrane-mediated signaling events.</clue>
<comment>NO CLUETYPE</comment></event>
<event id="E18">
<type class="Binding"/>
<theme idref="T29"/>
<theme idref="T33"/>
<clue>Freshly isolated T cells from lupus patients, rheumatoid arthritis (RA) patients, and normal individuals were activated physiologically via the TCR with anti-CD3 and anti-CD28 Abs to assess proximal membrane signaling, and <linkTheme>with</linkTheme> PMA and a calcium ionophore (A23187) to bypass membrane-mediated signaling events.</clue>
<comment>NO CLUETYPE</comment></event>
<event KT="Investigation" id="E19" uncertainty="doubtful">
<type class="Negative_regulation"/>
<theme idref="T34"/>
<cause idref="E15"/>
<clue>Freshly isolated T cells from lupus patients, rheumatoid arthritis (RA) patients, and normal individuals were activated physiologically via the TCR with anti-CD3 and anti-CD28 Abs to assess proximal membrane signaling, and with PMA and a calcium ionophore (A23187) <clueKT>to</clueKT> <clueType><clueKT>bypass</clueKT></clueType> membrane-mediated signaling events.</clue>
</event>
<event KT="Investigation" id="E20">
<type class="Negative_regulation"/>
<theme idref="T34"/>
<cause idref="E16"/>
<clue>Freshly isolated T cells from lupus patients, rheumatoid arthritis (RA) patients, and normal individuals were activated physiologically via the TCR with anti-CD3 and anti-CD28 Abs to assess proximal membrane signaling, and with PMA and a calcium ionophore (A23187) <clueKT>to</clueKT> <clueType><clueKT>bypass</clueKT></clueType> membrane-mediated signaling events.</clue>
</event>
<sentence id="S5">We measured the <term id="T35" lex="NF-kappa_B" sem="Protein_complex">NF-kappa B</term> binding activity in <term id="T36" lex="nuclear_extract" sem="Cell_component">nuclear extracts</term> by <term id="T37" lex="gel_shift_analysis" sem="Other">gel shift analysis</term>.</sentence>
<event KT="Investigation" id="E21" uncertainty="doubtful">
<type class="Binding"/>
<theme idref="T35"/>
<clue>We <clueKT>measured</clueKT> the NF-kappa B <clueType>binding activity</clueType> <clueLoc>in nuclear extracts</clueLoc> <clueExperiment>by gel shift analysis</clueExperiment>.</clue>
</event>
<sentence id="S6">When compared with <term id="T38" lex="normal_cell" sem="Cell_natural">normal cells</term>, the activation of <term id="T39" lex="NF-kappa_B_activity" sem="Other"><term id="T40" lex="NF-kappa_B" sem="Protein_complex">NF-kappa B</term> activity</term> in <term id="T41" lex="SLE" sem="Other">SLE</term> <term id="T42" lex="patient" sem="Multicellular_organism_natural">patients</term> was significantly decreased in <term id="T43" lex="SLE" sem="Other">SLE</term>, but not in <term id="T44" lex="RA" sem="Other">RA</term>, <term id="T45" lex="patient" sem="Multicellular_organism_natural">patients</term>.</sentence>
<event id="E22">
<type class="Positive_regulation"/>
<theme idref="T40"/>
<clue>When compared with normal cells, the <clueType>activation</clueType> <linkTheme>of</linkTheme> NF-kappa B activity <clueLoc>in SLE patients</clueLoc> was significantly decreased in SLE, but not in RA, patients.</clue>
<comment>CAUTION: clueLoc=T cells of SLE patients</comment></event>
<event Manner="High" id="E23">
<type class="Negative_regulation"/>
<theme idref="E22"/>
<clue>When compared with normal cells, the activation of NF-kappa B activity in SLE patients was <clueManner>significantly</clueManner> <clueType>decreased</clueType> <clueLoc>in SLE</clueLoc>, but not in RA, <clueLoc>patients</clueLoc>.</clue>
<comment>CAUTION: clueLoc=T cells of SLE patients</comment></event>
<event id="E33">
<type class="Positive_regulation"/>
<theme idref="T40"/>
<clue>When compared with normal cells, the <clueType>activation</clueType> <linkTheme>of</linkTheme> NF-kappa B activity <clueLoc>in SLE patients</clueLoc> was significantly decreased in SLE, but not in RA, patients.</clue>
<comment>CAUTION: SEE; clueLoc=T cells of RA patients</comment></event>
<event Manner="High" Polarity="Negative" assertion="non-exist" id="E24">
<type class="Negative_regulation"/>
<theme idref="E22"/>
<clue>When compared with normal cells, the activation of NF-kappa B activity in SLE patients was <clueManner>significantly</clueManner> <clueType>decreased</clueType> in SLE, but <cluePolarity>not</cluePolarity> <clueLoc>in RA, patients</clueLoc>.</clue>
<comment>CAUTION: clueLoc=T cells of RA patients</comment></event>
<event id="E34">
<type class="Positive_regulation"/>
<theme idref="T40"/>
<clue>When compared with <clueLoc>normal cells</clueLoc>, the <clueType>activation</clueType> <linkTheme>of</linkTheme> NF-kappa B activity in SLE patients was significantly decreased in SLE, but not in RA, patients.</clue>
<comment>CAUTION: SEE</comment></event>
<sentence id="S7"><term id="T46" lex="NF-kappa_B_binding_activity" sem="Other"><term id="T47" lex="NF-kappa_B" sem="Protein_complex">NF-kappa B</term> binding activity</term> was absent in several <term id="T48" lex="SLE" sem="Other">SLE</term> <term id="T49" lex="patient" sem="Multicellular_organism_natural">patients</term> who were not receiving any medication, including <term id="T50" lex="corticosteroid" sem="Lipid">corticosteroids</term>.</sentence>
<event Polarity="Negative" assertion="non-exist" id="E25">
<type class="Binding"/>
<theme idref="T47"/>
<clue>NF-kappa B <clueType>binding</clueType> activity was <clueType><cluePolarity>absent</cluePolarity></clueType> <clueLoc>in several SLE patients who were not receiving any medication, including corticosteroids</clueLoc>.</clue>
<comment>CAUTION: clueLoc=T cells of SLE patients</comment></event>
<sentence id="S8">Also, <term id="T51" lex="NF-kappa_B" sem="Protein_complex">NF-kappa B</term> activity remained absent in follow-up studies.</sentence>
<sentence id="S9">In supershift experiments using specific <term id="T52" lex="Ab" sem="Protein_family_or_group">Abs</term>, we showed that, in the group of <term id="T53" lex="SLE" sem="Other">SLE</term> <term id="T54" lex="patient" sem="Multicellular_organism_natural">patients</term> who displayed undetectable <term id="T55" lex="NF-kappa_B" sem="Protein_complex">NF-kappa B</term> activity, <term id="T56" lex="p65_complex" sem="Protein_complex">p65 complexes</term> were not formed.</sentence>
<event KT="Analysis" Manner="Low" assertion="non-exist" id="E27">
<type class="Positive_regulation"/>
<theme idref="T55"/>
<clue>In supershift experiments using specific Abs, we showed that, in the group of <clueLoc>SLE patients</clueLoc> who <clueType><clueKT>displayed</clueKT> <clueManner>undetectable</clueManner></clueType> NF-kappa B activity, p65 complexes were not formed.</clue>
<comment>CAUTION, clueType</comment></event>
<event KT="Analysis" Polarity="Negative" assertion="non-exist" id="E28">
<type class="Protein_metabolism"/>
<theme idref="T56"/>
<clue><clueExperiment>In supershift experiments using specific Abs</clueExperiment>, we <clueKT>showed</clueKT> that, in the group of <clueLoc>SLE patients</clueLoc> who displayed undetectable NF-kappa B activity, p65 complexes were <cluePolarity>not</cluePolarity> <clueType>formed</clueType>.</clue>
</event>
<sentence id="S10">Finally, <term id="T57" lex="immunoblot_analysis" sem="Other">immunoblot analysis</term> of <term id="T58" lex="nuclear_extract" sem="Cell_component">nuclear extracts</term> showed decreased or absent <term id="T59" lex="p65_protein_levels" sem="Other"><term id="T60" lex="p65_protein" sem="Protein_molecule">p65 protein</term> levels</term>.</sentence>
<event KT="Analysis" id="E29">
<type class="Negative_regulation"/>
<theme idref="T60"/>
<clue>Finally, <clueExperiment>immunoblot analysis</clueExperiment> <clueLoc>of nuclear extracts</clueLoc> <clueKT>showed</clueKT> <clueType>decreased or absent</clueType> p65 protein levels.</clue>
</event>
<sentence id="S11">As <term id="T61" lex="p65_complex" sem="Protein_complex">p65 complexes</term> are transcriptionally active in comparison to the <term id="A2" sem="Protein_complex">p50 homodimer</term>, this novel finding may provide insight on the origin of <term id="T62" lex="abnormal_cytokine" sem="Protein_family_or_group">abnormal <term id="A3" sem="DNA_domain_or_region">cytokine</term></term> or <term id="A4" sem="DNA_domain_or_region">other gene</term> transcription in <term id="T64" lex="SLE" sem="Other">SLE</term> <term id="T65" lex="patient" sem="Multicellular_organism_natural">patients</term>.</sentence>
<event KT="Fact" id="E30">
<type class="Positive_regulation"/>
<theme idref="T61"/>
<clue>As p65 complexes are <clueType>transcriptionally active</clueType> in comparison to the p50 homodimer, this novel finding may provide insight on the origin of abnormal cytokine or other gene transcription in SLE patients.</clue>
</event>
<event KT="Fact" Polarity="Negative" assertion="non-exist" id="E35">
<type class="Positive_regulation"/>
<theme idref="A2"/>
<clue>As p65 complexes are <clueType>transcriptionally active</clueType> <cluePolarity>in comparison to</cluePolarity> the p50 homodimer, this novel finding may provide insight on the origin of abnormal cytokine or other gene transcription in SLE patients.</clue>
<comment>CAUTION: SEE</comment></event>
<event KT="Other" id="E38">
<type class="Transcription"/>
<theme idref="A3"/>
<clue>As p65 complexes are transcriptionally active in comparison to the p50 homodimer, this novel finding may provide insight on the origin of <clueType>abnormal</clueType> cytokine or other gene <clueType>transcription</clueType> <clueLoc>in SLE patients</clueLoc>.</clue>
</event>
<event KT="Other" id="E39">
<type class="Transcription"/>
<theme idref="A4"/>
<clue>As p65 complexes are transcriptionally active in comparison to the p50 homodimer, this novel finding may provide insight on the origin of <clueType>abnormal</clueType> cytokine or other gene <clueType>transcription</clueType> <clueLoc>in SLE patients</clueLoc>.</clue>
</event>
</AbstractText>
</Abstract></Article></MedlineCitation></PubmedArticle></PubmedArticleSet></Annotation>
